Pharmaceutical execs pledge to increase COVID-19 vaccine output

279984

February 23, 2021

3 min read

Source/Disclosures

Disclosures: DeGette and Griffith report no relevant financial disclosures. Dobber, Hoge, Nettles, Trizzino and Young are employed by the pharmaceutical companies they represented.

ADD TOPIC TO EMAIL ALERTS

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

ADDED TO EMAIL ALERTS

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Pharmaceutical executives from Pfizer, Moderna, Johnson & Johnson, AstraZeneca and Novavax testified Tuesday that they are on track to deliver a combined 1.1 billion doses of COVID-19 vaccine in the United States by the end of July.

The executives answered questions from a House Energy & Commerce subcommittee on oversight and investigations. Their testimony came as the pace of the U.S. vaccine rollout continues to increase after a slow start.

Novavax Executive Vice President John Trizzino gives a short presentation on how the Novavax vaccine works against wild-type SARS-CoV-2, as well as variants…

Want to know more click here go to source.

From -
Close
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close